SCHEMBL2374565

SCHEMBL2374565

c1ccc2c(c1)CCN(c1ccnc(Nc3nccc4ccccc34)n1)C2

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR2C2 P49116 2/20 0.50
TAB1 Q15750 2/20 0.50
GRIN2D O15399 13/20 0.48
GRIN3B O60391 13/20 0.48
GRIN1 Q05586 13/20 0.48
GRIN2A Q12879 13/20 0.48
GRIN2B Q13224 13/20 0.48
GRIN2C Q14957 13/20 0.48
GRIN3A Q8TCU5 13/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
CHRM1 P11229 4/20 0.46
ADRA1D P25100 4/20 0.46
ADRA1A P35348 4/20 0.46
ADRA1B P35368 4/20 0.46
NUDT1 P36639 1/20 0.43
KDM6B O15054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31681837 1.00 NR2C2 (0.50) NR2C2TAB1GRIN2DGRIN3BGRIN1
SCHEMBL2373974 0.84 GRIN2D (0.60) NR2C2TAB1GRIN2DGRIN3BGRIN1
SCHEMBL31681849 0.84 GRIN2D (0.60) NR2C2TAB1GRIN2DGRIN3BGRIN1
SCHEMBL2374912 0.82 NR2C2 (0.59) NR2C2TAB1GRIN2DGRIN3BGRIN1
SCHEMBL31681833 0.82 NR2C2 (0.59) NR2C2TAB1GRIN2DGRIN3BGRIN1
SCHEMBL31681843 0.80 NR2C2 (0.57) NR2C2TAB1GRIN2DGRIN3BGRIN1
SCHEMBL2373960 0.80 GRIN2D (0.58) NR2C2TAB1GRIN2DGRIN3BGRIN1
SCHEMBL31681832 0.80 GRIN2D (0.58) NR2C2TAB1GRIN2DGRIN3BGRIN1
SCHEMBL2374684 0.80 NR2C2 (0.57) NR2C2TAB1GRIN2DGRIN3BGRIN1
SCHEMBL2375868 0.78 NR2C2 (0.53) NR2C2TAB1GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4585589-A2 STEM CELL CULTURES The Scripps Research Institute (US) 2025-07-16 EP disclosed
EP-4296270-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2025-06-18 EP disclosed
EP-4296270-A2 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2023-12-27 EP disclosed
EP-3936508-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2023-12-06 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
EP-3623374-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2021-09-08 EP disclosed
EP-3623374-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2021-09-08 EP disclosed
EP-2370445-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2014-07-23 EP disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294761-A1 STEM CELL CULTURES NES, CD44, MCL1 NR2C2 4665/4885TAB1 4078/4885GRIN2D 2800/4885
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS MCL1, BCL2, BCLAF1 NR2C2 4298/4885TAB1 4554/4885GRIN2D 4046/4885
US-20110224233-A1 STEM CELL CULTURES NES, CD44, MCL1 NR2C2 4665/4885TAB1 4078/4885GRIN2D 2800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.